• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的心血管风险评估分数:一项系统综述

Cardiovascular risk assessment scores for people with diabetes: a systematic review.

作者信息

Chamnan P, Simmons R K, Sharp S J, Griffin S J, Wareham N J

机构信息

Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.

出版信息

Diabetologia. 2009 Oct;52(10):2001-14. doi: 10.1007/s00125-009-1454-0. Epub 2009 Jul 24.

DOI:10.1007/s00125-009-1454-0
PMID:19629430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2744770/
Abstract

People with type 2 diabetes have an increased risk of cardiovascular disease (CVD). Multivariate cardiovascular risk scores have been used in many countries to identify individuals who are at high risk of CVD. These risk scores include those originally developed in individuals with diabetes and those developed in a general population. This article reviews the published evidence for the performance of CVD risk scores in diabetic patients by: (1) examining the overall rationale for using risk scores; (2) systematically reviewing the literature on available scores; and (3) exploring methodological issues surrounding the development, validation and comparison of risk scores. The predictive performance of cardiovascular risk scores varies substantially between different populations. There is little evidence to suggest that risk scores developed in individuals with diabetes estimate cardiovascular risk more accurately than those developed in the general population. The inconsistency in the methods used in evaluation studies makes it difficult to compare and summarise the predictive ability of risk scores. Overall, CVD risk scores rank individuals reasonably accurately and are therefore useful in the management of diabetes with regard to targeting therapy to patients at highest risk. However, due to the uncertainty in estimation of true risk, care is needed when using scores to communicate absolute CVD risk to individuals.

摘要

2型糖尿病患者患心血管疾病(CVD)的风险增加。多变量心血管风险评分已在许多国家用于识别心血管疾病高风险个体。这些风险评分包括最初在糖尿病患者中开发的评分以及在普通人群中开发的评分。本文通过以下方式综述了已发表的关于糖尿病患者心血管疾病风险评分表现的证据:(1)审视使用风险评分的总体基本原理;(2)系统回顾关于现有评分的文献;(3)探讨围绕风险评分的开发、验证和比较的方法学问题。心血管疾病风险评分在不同人群中的预测表现差异很大。几乎没有证据表明在糖尿病患者中开发的风险评分比在普通人群中开发的评分更准确地估计心血管疾病风险。评估研究中使用的方法不一致,使得难以比较和总结风险评分的预测能力。总体而言,心血管疾病风险评分对个体的排名相当准确,因此在糖尿病管理中,针对风险最高的患者进行靶向治疗时很有用。然而,由于真实风险估计存在不确定性,在使用评分向个体传达绝对心血管疾病风险时需要谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d3/2744770/8fb5d6274f91/125_2009_1454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d3/2744770/8fb5d6274f91/125_2009_1454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d3/2744770/8fb5d6274f91/125_2009_1454_Fig1_HTML.jpg

相似文献

1
Cardiovascular risk assessment scores for people with diabetes: a systematic review.糖尿病患者的心血管风险评估分数:一项系统综述
Diabetologia. 2009 Oct;52(10):2001-14. doi: 10.1007/s00125-009-1454-0. Epub 2009 Jul 24.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
5
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
6
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
7
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
10
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.

引用本文的文献

1
Predicting the risks of stroke, cardiovascular disease, and peripheral vascular disease among people with type 2 diabetes with artificial intelligence models: A systematic review and meta-analysis.使用人工智能模型预测2型糖尿病患者中风、心血管疾病和外周血管疾病的风险:一项系统综述和荟萃分析。
Narra J. 2025 Apr;5(1):e2116. doi: 10.52225/narra.v5i1.2116. Epub 2025 Mar 19.
2
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.多基因评分在2型糖尿病中的临床应用:挑战与机遇
Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419-1.
3
Social Determinants of Health and Cardiovascular Risk among Adults with Diabetes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

本文引用的文献

1
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.英国前瞻性糖尿病研究风险引擎和弗雷明汉风险方程在评估欧洲癌症与营养前瞻性调查诺福克队列心血管疾病方面的表现。
Diabetes Care. 2009 Apr;32(4):708-13. doi: 10.2337/dc08-1918. Epub 2008 Dec 29.
2
The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial.个性化心血管疾病(CVD)风险评估和生活方式建议对CVD高危个体身体活动的影响:一项2×2析因性理解风险试验的试点研究
Cardiovasc Diabetol. 2008 Jul 17;7:21. doi: 10.1186/1475-2840-7-21.
3
社会决定因素与糖尿病患者心血管风险:地理和种族差异导致中风的原因(REGARDS)研究。
Diabetes Metab J. 2024 Nov;48(6):1073-1083. doi: 10.4093/dmj.2023.0380. Epub 2024 Jul 22.
4
External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study.对 2 型糖尿病阿曼患者心血管风险模型的外部验证:一项回顾性队列研究。
BMJ Open. 2023 Nov 15;13(11):e071369. doi: 10.1136/bmjopen-2022-071369.
5
Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project.机器学习在糖尿病患者心血管风险评估中的应用:西里西亚糖尿病-心脏项目。
Cardiovasc Diabetol. 2023 Aug 24;22(1):218. doi: 10.1186/s12933-023-01938-w.
6
Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database.使用国家医疗索赔数据库建立的2型糖尿病患者严重并发症和死亡率短期年度风险预测模型。
Diabetol Metab Syndr. 2023 Jun 15;15(1):128. doi: 10.1186/s13098-023-01105-x.
7
Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018.2014 年至 2018 年期间泰国 2 型糖尿病患者心血管疾病 10 年预测风险的趋势。
BMC Cardiovasc Disord. 2023 Apr 5;23(1):183. doi: 10.1186/s12872-023-03217-8.
8
Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults.老年成年人中糖尿病诊断年龄和病程与发病率及死亡率的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2232766. doi: 10.1001/jamanetworkopen.2022.32766.
9
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告:2 型糖尿病患者高血糖管理。
Diabetologia. 2022 Dec;65(12):1925-1966. doi: 10.1007/s00125-022-05787-2. Epub 2022 Sep 24.
10
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 共识报告:2 型糖尿病患者高血糖管理。
Diabetes Care. 2022 Nov 1;45(11):2753-2786. doi: 10.2337/dci22-0034.
Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register.
2型糖尿病患者心血管疾病的风险预测:来自瑞典国家糖尿病登记处的风险方程
Diabetes Care. 2008 Oct;31(10):2038-43. doi: 10.2337/dc08-0662. Epub 2008 Jun 30.
4
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?在欧洲癌症与营养前瞻性调查-诺福克队列中对弗雷明汉风险评分的评估:添加糖化血红蛋白是否能改善冠心病事件的预测?
Arch Intern Med. 2008 Jun 9;168(11):1209-16. doi: 10.1001/archinte.168.11.1209.
5
Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.2型糖尿病患者冠心病总风险评分的制定与验证
Am J Cardiol. 2008 Mar 1;101(5):596-601. doi: 10.1016/j.amjcard.2007.10.019. Epub 2007 Dec 21.
6
Effect of a multifactorial intervention on mortality in type 2 diabetes.多因素干预对2型糖尿病患者死亡率的影响。
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.
7
Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial.一项基于理论的行为干预措施对增加基层医疗中高危人群身体活动量的效果(英国主动干预研究):一项随机试验
Lancet. 2008 Jan 5;371(9606):41-8. doi: 10.1016/S0140-6736(08)60070-7.
8
Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).对M. J. 彭西纳等人发表于《医学统计学》(DOI: 10.1002/sim.2929)的《评估新标志物的附加预测能力:从ROC曲线下面积到重新分类及其他》的评论
Stat Med. 2008 Jan 30;27(2):173-81. doi: 10.1002/sim.2991.
9
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.评估新标志物的附加预测能力:从ROC曲线下面积到重新分类及其他。
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12. doi: 10.1002/sim.2929.
10
Prediction of first coronary events with the Framingham score: a systematic review.使用弗雷明汉评分法预测首次冠状动脉事件:一项系统评价。
Am Heart J. 2007 May;153(5):722-31, 731.e1-8. doi: 10.1016/j.ahj.2007.02.027.